CN100361656C - 丁苯酞自乳化释药体系及其制备方法和应用 - Google Patents

丁苯酞自乳化释药体系及其制备方法和应用 Download PDF

Info

Publication number
CN100361656C
CN100361656C CNB2004100750682A CN200410075068A CN100361656C CN 100361656 C CN100361656 C CN 100361656C CN B2004100750682 A CNB2004100750682 A CN B2004100750682A CN 200410075068 A CN200410075068 A CN 200410075068A CN 100361656 C CN100361656 C CN 100361656C
Authority
CN
China
Prior art keywords
emulsifying
butyphthalide
self emulsifying
butylbenzene phthalein
releasing medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB2004100750682A
Other languages
English (en)
Chinese (zh)
Other versions
CN1726909A (zh
Inventor
刘振涛
杨丽英
杨汉煜
高玉清
申东民
郭文敏
冯小龙
郑嘉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHIJIAZHUAN PHARMA GROUP NBP PHARMACEUTICAL Co Ltd
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Original Assignee
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CNB2004100750682A priority Critical patent/CN100361656C/zh
Application filed by CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd filed Critical CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Priority to KR1020077006741A priority patent/KR100887034B1/ko
Priority to US11/574,313 priority patent/US8728518B2/en
Priority to ES05781769T priority patent/ES2341265T4/es
Priority to AT05781769T priority patent/ATE462410T1/de
Priority to MX2007002335A priority patent/MX2007002335A/es
Priority to PCT/CN2005/001332 priority patent/WO2006021160A1/zh
Priority to BRPI0515070A priority patent/BRPI0515070B8/pt
Priority to AU2005276811A priority patent/AU2005276811B8/en
Priority to RU2007111120/15A priority patent/RU2371176C2/ru
Priority to CA2578130A priority patent/CA2578130C/en
Priority to EP05781769A priority patent/EP1787638B1/en
Priority to DE602005020317T priority patent/DE602005020317D1/de
Priority to JP2007528562A priority patent/JP4653810B2/ja
Publication of CN1726909A publication Critical patent/CN1726909A/zh
Priority to NO20071354A priority patent/NO336917B1/no
Application granted granted Critical
Publication of CN100361656C publication Critical patent/CN100361656C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB2004100750682A 2004-08-27 2004-08-27 丁苯酞自乳化释药体系及其制备方法和应用 Expired - Lifetime CN100361656C (zh)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CNB2004100750682A CN100361656C (zh) 2004-08-27 2004-08-27 丁苯酞自乳化释药体系及其制备方法和应用
CA2578130A CA2578130C (en) 2004-08-27 2005-08-26 Butylbenzene phthalein self-emulsifying drug delivery system, its preparation method and application
ES05781769T ES2341265T4 (es) 2004-08-27 2005-08-26 Sistema de administración de fármaco autoemulsionante de butilbenceno ftaleína su procedimiento de preparación y aplicación.
AT05781769T ATE462410T1 (de) 2004-08-27 2005-08-26 Selbstemulgierendes butylbenzolphthalein- arzneimittelabgabesystem, sein herstellungsverfahren und seine anwendung
MX2007002335A MX2007002335A (es) 2004-08-27 2005-08-26 Sistema de liberacion de farmaco de auto-emulsificacion de butilftalato, metodo para su preparacion y aplicacion.
PCT/CN2005/001332 WO2006021160A1 (en) 2004-08-27 2005-08-26 Butylbenzene phthalein self-emulsifying drug delivery system, its preparation method and application
BRPI0515070A BRPI0515070B8 (pt) 2004-08-27 2005-08-26 sistema de entrega de medicamentos auto-emulsificante de butilftalida e processo para a preparação do sistema de entrega de medicamentos auto-emulsificante de butilftalida
AU2005276811A AU2005276811B8 (en) 2004-08-27 2005-08-26 Butylphthalide self-emulsifying drug delivery system, its preparation method and application
KR1020077006741A KR100887034B1 (ko) 2004-08-27 2005-08-26 부틸프탈라이드 자가 에멀젼화 약물 전달 시스템, 그 제조방법 및 응용
US11/574,313 US8728518B2 (en) 2004-08-27 2005-08-26 Butylphthalide self-emulsifying drug delivery system, its preparation and method and application
EP05781769A EP1787638B1 (en) 2004-08-27 2005-08-26 Butylbenzene phthalein self-emulsifying drug delivery system, its preparation method and application
DE602005020317T DE602005020317D1 (de) 2004-08-27 2005-08-26 Selbstemulgierendes butylbenzolphthalein-arzneimittelabgabesystem, sein herstellungsverfahren und seine anwendung
JP2007528562A JP4653810B2 (ja) 2004-08-27 2005-08-26 ブチルフタリド自己乳化薬物送達システム、その調製方法および用途
RU2007111120/15A RU2371176C2 (ru) 2004-08-27 2005-08-26 Самоэмульгирующаяся система доставки лекарственного средства бутилфталида, способ ее получения и применения
NO20071354A NO336917B1 (no) 2004-08-27 2007-03-12 Butylftalid selvemulgerende medikamentavgivelsessystem, samt fremgangsmåter for fremstilling og anvendelse av samme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100750682A CN100361656C (zh) 2004-08-27 2004-08-27 丁苯酞自乳化释药体系及其制备方法和应用

Publications (2)

Publication Number Publication Date
CN1726909A CN1726909A (zh) 2006-02-01
CN100361656C true CN100361656C (zh) 2008-01-16

Family

ID=35926548

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100750682A Expired - Lifetime CN100361656C (zh) 2004-08-27 2004-08-27 丁苯酞自乳化释药体系及其制备方法和应用

Country Status (15)

Country Link
US (1) US8728518B2 (enExample)
EP (1) EP1787638B1 (enExample)
JP (1) JP4653810B2 (enExample)
KR (1) KR100887034B1 (enExample)
CN (1) CN100361656C (enExample)
AT (1) ATE462410T1 (enExample)
AU (1) AU2005276811B8 (enExample)
BR (1) BRPI0515070B8 (enExample)
CA (1) CA2578130C (enExample)
DE (1) DE602005020317D1 (enExample)
ES (1) ES2341265T4 (enExample)
MX (1) MX2007002335A (enExample)
NO (1) NO336917B1 (enExample)
RU (1) RU2371176C2 (enExample)
WO (1) WO2006021160A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100367951C (zh) 2005-12-16 2008-02-13 石药集团恩必普药业有限公司 丁苯酞静脉乳剂及其应用
CN101342152B (zh) * 2007-07-10 2010-10-13 石药集团中奇制药技术（石家庄）有限公司 丁苯酞片及其制备方法
CN101579323B (zh) * 2008-05-16 2012-01-25 石药集团中奇制药技术（石家庄）有限公司 丁苯酞缓释片及其制备方法
CN102178643B (zh) * 2011-04-29 2014-05-14 石药集团恩必普药业有限公司 一种丁苯酞或其衍生物的微乳透皮凝胶剂及其制备方法
CN103784424B (zh) * 2012-10-30 2018-04-27 石药集团中奇制药技术（石家庄）有限公司 一种丁苯酞经皮贴剂及其制备方法
CN103830200A (zh) * 2012-11-21 2014-06-04 石药集团中奇制药技术（石家庄）有限公司 一种3-正丁基苯酞衍生物的组合物及其制备方法
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
TWI547280B (zh) * 2014-04-24 2016-09-01 長弘生物科技股份有限公司 穩定醫藥組合物
CN105030760B (zh) 2014-04-24 2018-10-02 长弘生物科技股份有限公司 稳定医药组合物
CA2982162C (en) * 2015-04-10 2023-10-10 Bioresponse, L.L.C. Self-emulsifying formulations of dim-related indoles
CN105267145B (zh) * 2015-11-01 2019-06-21 袁旭东 双膦酸盐的自乳化配方和相关剂型
CN105796486A (zh) * 2016-03-17 2016-07-27 南京天翔医药科技有限公司 丁苯酞脂肪乳注射剂及其制备工艺
CN107661287B (zh) * 2017-11-28 2021-01-26 遵义医学院 地榆皂苷自乳化药物传递系统的制备
CN110856712B (zh) * 2018-08-06 2021-11-30 刘超 丁苯酞自微乳组合物及其制备方法和用途
CN114073694B (zh) * 2020-08-14 2024-03-12 北京科莱博医药开发有限责任公司 丁苯酞制剂及其制备方法
CN114681389A (zh) * 2020-12-29 2022-07-01 中国科学院上海药物研究所 一种经口腔黏膜递送的丁苯酞组合物及其用途
CN116407510B (zh) * 2021-12-29 2025-11-21 河北赛谱睿思医药科技有限公司 一种丁苯酞舌下片及其制备方法
KR20250092933A (ko) * 2023-12-15 2025-06-24 한국 한의학 연구원 부틸프탈라이드 또는 이의 허용 가능한 염을 유효성분으로 포함하는 노화에 의한 난소 저반응군의 예방, 개선 또는 치료용 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1375288A (zh) * 2002-05-13 2002-10-23 周桂荣 一种治疗脑血管疾病的药物组合物
CN1394880A (zh) * 2001-06-18 2003-02-05 石家庄制药集团制药技术开发有限公司 丁苯酞环糊精或环糊精衍生物包合物及其制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2516477B2 (ja) * 1990-12-17 1996-07-24 花王株式会社 皮膚の血行不良に起因する疾患の治療剤
CN2123000U (zh) 1992-04-24 1992-11-25 李广杰 塑料葡萄灯
DE4313693A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
CN1048158C (zh) 1993-09-09 2000-01-12 中国医学科学院药物研究所 芹菜甲素在制备预防和治疗哺乳动物或人类脑缺血引起的疾病的药中的应用
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN100341485C (zh) 1998-04-01 2007-10-10 斯凯伊药品加拿大公司 抗癌组合物
JP2002513750A (ja) * 1998-05-07 2002-05-14 エラン コーポレーシヨン ピーエルシー 溶媒／助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム
CN1086942C (zh) 1998-12-18 2002-07-03 中国医学科学院药物研究所 丁基苯酞在制备抗血栓形成及抗血小板聚集药物中的应用
MY120392A (en) * 2000-06-08 2005-10-31 Hovid Berhad A novel drug delivery system : formulation for fat-soluble drugs
US6596306B1 (en) * 2000-07-07 2003-07-22 David Ho Sue San Ho Drug delivery system:formulation for fat-soluble drugs
SG97918A1 (en) * 2000-06-08 2003-08-20 Hovid Sdn Bhd A novel drug delivery system: formulation for fat-soluble drugs
CA2410683A1 (en) * 2000-07-24 2002-01-31 Pharmacia & Upjohn Company Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
ATE489972T1 (de) * 2002-08-21 2010-12-15 Shijiazhuang Pharma Group Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd Einschlusskomplexe aus butylphthalid und cyclodextrin derivaten und verfahren zu deren herstellung
JP4215633B2 (ja) 2002-12-19 2009-01-28 Ｊｆｅケミカル株式会社 複合黒鉛粒子の製造方法
CN1233317C (zh) * 2003-07-07 2005-12-28 西安利君制药有限责任公司 水飞蓟素自乳化微乳组合物及其制备工艺

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1394880A (zh) * 2001-06-18 2003-02-05 石家庄制药集团制药技术开发有限公司 丁苯酞环糊精或环糊精衍生物包合物及其制备方法和用途
CN1375288A (zh) * 2002-05-13 2002-10-23 周桂荣 一种治疗脑血管疾病的药物组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
自乳化释药系统的研究进展. 李国栋等.国外医药 合成药 生化药 制剂分册，第22卷第5期. 2001 *

Also Published As

Publication number Publication date
NO20071354L (no) 2007-05-29
US8728518B2 (en) 2014-05-20
WO2006021160A8 (fr) 2006-04-13
AU2005276811B8 (en) 2009-01-22
JP4653810B2 (ja) 2011-03-16
RU2007111120A (ru) 2008-10-20
JP2008510737A (ja) 2008-04-10
CA2578130C (en) 2010-08-31
BRPI0515070A2 (pt) 2009-08-04
KR20070046948A (ko) 2007-05-03
ATE462410T1 (de) 2010-04-15
WO2006021160A1 (en) 2006-03-02
CA2578130A1 (en) 2006-03-02
AU2005276811B2 (en) 2008-11-13
BRPI0515070B8 (pt) 2021-05-25
DE602005020317D1 (de) 2010-05-12
EP1787638A4 (en) 2008-12-03
EP1787638A1 (en) 2007-05-23
CN1726909A (zh) 2006-02-01
RU2371176C2 (ru) 2009-10-27
NO336917B1 (no) 2015-11-23
MX2007002335A (es) 2007-10-10
AU2005276811A1 (en) 2006-03-02
ES2341265T3 (es) 2010-06-17
ES2341265T4 (es) 2011-04-27
EP1787638B1 (en) 2010-03-31
US20080319056A1 (en) 2008-12-25
BRPI0515070B1 (pt) 2020-09-08
KR100887034B1 (ko) 2009-03-04

Similar Documents

Publication Publication Date Title
CN100361656C (zh) 丁苯酞自乳化释药体系及其制备方法和应用
JP4815053B2 (ja) 経口投与の固形投与形態物としてのマイクロエマルション
KR100415897B1 (ko) 생체 이용율이 높은 페노피브레이트 제약학적 조성물
US6524615B2 (en) Controlled release pharmaceutical composition
JP2002522473A5 (enExample)
WO2002011701A1 (en) A controlled release pharmaceutical composition
RU2262922C2 (ru) Способ прессования для получения лекарственной формы фенитоина натрия
JPH0625064B2 (ja) 制御放出塩化カリウム
JP2008510737A5 (enExample)
JP2019163327A (ja) 三種混合製剤
US20040001888A1 (en) Solid dosage forms for rapid dissolution of poorly soluble drugs
CN102697765B (zh) 盐酸雷尼替丁枸橼酸铋钾药物组合物固体脂质纳米粒制剂
CN103169685A (zh) 一种丁苯酞控释制剂及其制备方法
Renthlei et al. Floating Drug Delivery System: An Outlook
CN121041272A (zh) 丁苯酞固体释药体系及其制备方法和药物片剂
CN115645422A (zh) 用于预防和治疗代谢综合征的组合物及其用途
CN1969829A (zh) 包封氯氮平的固体脂质微颗粒及其制备方法
CN102309476A (zh) 非诺贝特组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: ENBIPU PHARMACY CO., LTD., SHIYAO GROUP.

Effective date: 20130319

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 050051 SHIJIAZHUANG, HEBEI PROVINCE TO: 050035 SHIJIAZHUANG, HEBEI PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130319

Address after: 050035 No. 226 the Yellow River Avenue, Shijiazhuang hi tech Development Zone, Hebei

Patentee after: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) Co.,Ltd.

Patentee after: SHIJIAZHUAN PHARMA GROUP NBP PHARMACEUTICAL Co.,Ltd.

Address before: 050051 No. 276 West Zhongshan Road, Hebei, Shijiazhuang

Patentee before: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) Co.,Ltd.

CX01 Expiry of patent term

Granted publication date: 20080116

CX01 Expiry of patent term